ESPR - Esperion Therapeutics, Inc.
IEX Last Trade
2.245
-0.065 -2.895%
Share volume: 200
Last Updated: Fri 27 Dec 2024 03:30:02 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.05%
PREVIOUS CLOSE
CHG
CHG%
$2.31
-0.07
-2.81%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-02 | 2022-11-01 | 2023-02-21 | 2023-05-09 | 2023-08-01 | 2023-11-07 | 2024-02-27 | 2024-05-07 | |
| Total revenue | 18.841 M | 18.980 M | 18.818 M | 24.329 M | 25.786 M | 33.969 M | 32.250 M | 137.735 M | |
| Cost of revenue | 9.176 M | 6.506 M | 4.160 M | 11.652 M | 6.786 M | 13.377 M | 11.452 M | 10.075 M | |
| Gross profit | 9.665 M | 12.474 M | 14.658 M | 12.677 M | 19.000 M | 20.592 M | 20.798 M | 127.660 M | |
| 29.06% | 17.51% | -13.51% | 49.88% | 8.38% | 1.00% | 513.81% | |||
| Operating expenses | 62.041 M | 54.097 M | 57.171 M | 61.282 M | 56.058 M | 48.125 M | 63.165 M | 55.391 M | |
| Selling general and admin | 29.609 M | 24.954 M | 24.138 M | 29.901 M | 33.959 M | 33.240 M | 45.423 M | 41.988 M | |
| Research and development | 32.432 M | 29.143 M | 33.033 M | 31.381 M | 22.099 M | 14.885 M | 17.742 M | 13.403 M | |
| Total expenses | 71.217 M | 60.603 M | 61.331 M | 72.934 M | 62.844 M | 61.502 M | 74.617 M | 65.466 M | |
| -14.90% | 1.20% | 18.92% | -13.83% | -2.14% | 21.32% | -12.26% | |||
| Operating income | -52.376 M | -41.623 M | -42.513 M | -48.605 M | -37.058 M | -27.533 M | -42.367 M | 72.269 M | |
| Ebit | -52.376 M | -41.623 M | -42.513 M | -48.605 M | -37.058 M | -27.533 M | -42.367 M | 72.269 M | |
| Pretax income | -66.324 M | -55.117 M | -55.487 M | -61.719 M | -49.935 M | -41.250 M | -56.344 M | 61.022 M | |
| -16.90% | 0.67% | 11.23% | -19.09% | -17.39% | 36.59% | -208.30% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -66.324 M | -55.117 M | -55.487 M | -61.719 M | -49.935 M | -41.250 M | -56.344 M | 61.022 M | |
| 16.90% | -0.67% | -11.23% | 19.09% | 17.39% | -36.59% | 208.30% | |||
| Net income | -66.324 M | -55.117 M | -55.487 M | -61.719 M | -49.935 M | -41.250 M | -56.344 M | 61.022 M | |
| 16.90% | -0.67% | -11.23% | 19.09% | 17.39% | -36.59% | 208.30% |